Harold Bernstein

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Courtney Phillips, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harold Bernstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Maze Therapeutics, Inc. President, R&D & CMO Common Stock 0 $0 $47.23 02 Feb 2026 Direct
Maze Therapeutics, Inc. President, R&D & CMO Stock Option (Right to Buy) 297,407 02 Feb 2026 Direct
Maze Therapeutics, Inc. President, R&D & CMO Restricted Stock Units 40,000 22 Sep 2025 Direct

Insider Reports Filed by Harold Bernstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MAZE Maze Therapeutics, Inc. 02 Feb 2026 6 -$534,034 4 President, R&D & CMO 04 Feb 2026, 16:25
MAZE Maze Therapeutics, Inc. 07 Jan 2026 3 -$749,173 4 President, R&D & CMO 09 Jan 2026, 16:51
MAZE Maze Therapeutics, Inc. 02 Jan 2026 6 -$145,193 4 President, R&D & CMO 06 Jan 2026, 16:31
MAZE Maze Therapeutics, Inc. 29 Dec 2025 4 -$1,356,455 4 President, R&D & CMO 31 Dec 2025, 16:22
MAZE Maze Therapeutics, Inc. 22 Sep 2025 1 $0 4 President, R&D & CMO 24 Sep 2025, 16:24
MAZE Maze Therapeutics, Inc. 30 Jan 2025 0 $0 3 President, R&D & CMO 30 Jan 2025, 16:22